Who Owns Charles River Laboratories International Inc
Every manager with more than $100m in listed equities files a 13F each quarter naming what they hold. These are the ones reporting a position in Charles River Laboratories International Inc.
Who crossed 5% of CRL →Positions as of 2026-09-30
Largest first. The move is against the previous quarter that manager filed, not the previous calendar quarter.
| Manager | Value |
|---|---|
| GAMMA Investing LLCCommon Stock4.4K shadded | $1.3M |
| Everhart Financial Group, Inc.COM3K shadded | $876.2K |
| Lake Hills Wealth Management, LLCCOM2.5K sh— | $745.8K |
| Farther Finance Advisors, LLCStock2.3K shadded | $681.8K |
| Wedmont Private CapitalCOM930 sh— | $277.1K |
| MassMutual Private Wealth & Trust, FSBCommon / Ordinary Stock350 shtrimmed | $103.3K |
| CoreCap Advisors, LLCStock60 shadded | $17.7K |
| ELEVATION WEALTH PARTNERS, LLCCOM36 shheld | $10.6K |
| Byrne Asset Management LLCCOM28 shheld | $8K |
| Grove Bank & TrustCOM17 shheld | $5K |
| Retirement Wealth Solutions LLCCOM12 shadded | $3.5K |
| Marquette Asset Management, LLCCOM7 shheld | $2.1K |
Source: quarterly 13F filings, via EDGAR. A 13F reports positions by CUSIP alone; each CUSIP here has been confirmed against OpenFIGI rather than matched by name, because a name match would attribute one company's shareholders to another. Positions are as of quarter end and can be months old by the time they are filed, and 13F covers long equity positions only — not shorts, and not most debt. The summed value is what these filers reported, not the company's institutional ownership.
More on CRL
Follow Charles River Laboratories International Inc (CRL) by email
New trades in Charles River Laboratories International Inc (CRL) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.